Skip to main content
Oxford University Hospitals NHS Foundation Trust

Alert Coronavirus / COVID-19

If you have a new continuous cough, a high temperature, or a loss or change to your sense of taste or smell, do not come to our hospitals. Follow the national advice on coronavirus (COVID-19).

Please find information on our services and visiting restrictions in our COVID-19 section.

Patients and visitors must wear a face covering in our hospitals.

This site is best viewed with a modern browser. You appear to be using an old version of Internet Explorer.

Neurology and neuromuscular disorders

The laboratory provides the following services (R codes relate to the NHS England National Genomic Test Directory).

Testing for previously identified familial variants, as clinically appropriate, is available.

Neuromuscular disorders

  • R80 Congenital Myasthenic Syndromes
  • R73 Duchenne or Becker muscular dystrophy
  • R378 Duchenne or Becker muscular dystrophy linkage testing in families
  • R72 Myotonic dystrophy Type 1
  • R410 Myotonic dystrophy Type 2

Neurodegenerative disorders

  • R68 Huntington disease
  • R383 Huntington disease exclusion testing by linkage
  • R58 Adult onset neurodegenerative disorders, including ALS & MND
  • R54 Hereditary ataxia with onset in adulthood
  • R55 Hereditary ataxia with onset in childhood and R84 Cerebellar anomalies (same gene panel)

Other neurological disorders

  • R59 Early onset or syndromic Epilepsy
  • R66 Paroxysmal central nervous system disorders
  • R87 Cerebral malformations
  • R84 Cerebellar anomalies and R55 Hereditary ataxia with onset in childhood (same gene panel)


The laboratory works closely with Professor David Beeson's research group at the Weatherall Institute of Molecular Medicine, University of Oxford, who provide functional studies of variants in genes associated with congenital myasthenia syndrome.